Clinical trial · Observational
F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
Comparison of F-18 FDG PET/CT and CT in Initial Staging of Non-small Lung Cancer
NCT06789562CI-TRIAL-00084986not yet recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Is to compare F-18 FDG PET/CT to routine CT in staging of non-small lung cancer and effect on change management.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| F-18FDG PET/CT and CT | Device | — | UNRESOLVED |
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (1)
- measure
- compare F-18 FDG PET/CT to routine CT in staging of non-small lung cancer and effect on change management.
- timeFrame
- Baseline
- description
- detect added value of F-18FDG PET/CT .
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients with pathologically proven NSCLC who underwent initial PET/CT images. * All patients ≥ 18 years. Exclusion Criteria: * Patients who had started treatment before initial PET/CT. Patients with glucose level \< 200 mg/dl. Patients with another malignant condition.
References
Publications (1)
- BACKGROUNDHadar R, Slonim A, Kuhn J. Role of D-tryptophan oxidase in D-tryptophan utilization by Escherichia coli. J Bacteriol. 1976 Mar;125(3):1096-1104. doi: 10.1128/jb.125.3.1096-1104.1976. PMID 3493